MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer

Digestive and Liver Disease

Volumn 44, Issue 7, 2012, Pages 589-596

  Yamanaka, Sumitaka ^a   Olaru, Alexandru V ^a   An, Fangmei ^a   Luvsanjav, Delgermaa ^a   Jin, Zhe ^a   Agarwal, Rachana ^a   Tomuleasa, Ciprian ^a,b   Popescu, Irinel ^c   Alexandrescu, Sorin ^c   Dima, Simona ^c   Chivu Economescu, Mihaela ^d   Montgomery, Elizabeth A ^e   Torbenson, Michael ^e   Meltzer, Stephen J ^a   Selaru, Florin M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c FUNDENI CLINICAL INSTITUTE   (Romania)

^d STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Gastric cancer; MicroRNA 21; Serpini1 gene

Indexed keywords

COMPLEMENTARY DNA; LUCIFERASE; MICRORNA 21; NEUROSERPIN;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DOWN REGULATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOLECULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; UPREGULATION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEUROPEPTIDES; RNA, MESSENGER; SERPINS; STOMACH NEOPLASMS; TRANSFECTION; UP-REGULATION;

EID: 84861344982     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.02.016     Document Type: Article

References (50)

1. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
2. Shi Y., Zhou Y. The role of surgery in the treatment of gastric cancer. J Surg Oncol 2010, 101:687-692.
3. Han H.J., Yanagisawa A., Kato Y., et al. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993, 53:5087-5089.
4. Rhyu M.G., Park W.S., Meltzer S.J. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 1994, 9:29-32.
5. Nakashima H., Inoue H., Mori M., et al. Microsatellite instability in Japanese gastric cancer. Cancer 1995, 75:1503-1507.
6. Tamura G., Sakata K., Maesawa C., et al. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 1995, 55:1933-1936.
7. Schmutte C., Baffa R., Veronese L.M., et al. Human thymine-DNA glycosylase maps at chromosome 12q22-q24.1: a region of high loss of heterozygosity in gastric cancer. Cancer Res 1997, 57:3010-3015.
8. Fleisher A.S., Esteller M., Wang S., et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999, 59:1090-1095.
9. Suzuki H., Itoh F., Toyota M., et al. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999, 83:309-313.
10. Yamamoto H., Perez-Piteira J., Yoshida T., et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999, 116:1348-1357.
11. Leung S.Y., Yuen S.T., Chung L.P., et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999, 59:159-164.
12. Toyota M., Ahuja N., Suzuki H., et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 1999, 59:5438-5442.
13. Toyota M., Ho C., Ohe-Toyota M., et al. Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumours. Cancer Res 1999, 59:4535-4541.
14. Tsuchiya T., Tamura G., Sato K., et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000, 19:3642-3646.
15. Tamura G., Yin J., Wang S., et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 2000, 92:569-573.
16. Fleisher A.S., Esteller M., Tamura G., et al. Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia. Oncogene 2001, 20:329-335.
17. Hippo Y., Taniguchi H., Tsutsumi S., et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002, 62:233-240.
18. Matsui S., Shiozaki H., Inoue M., et al. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch 1994, 424:375-381.
19. Baffa R., Veronese M.L., Santoro R., et al. Loss of FHIT expression in gastric carcinoma. Cancer Res 1998, 58:4708-4714.
20. Shun C.T., Wu M.S., Lin J.T., et al. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer. Hepatogastroenterology 1998, 45:944-949.
21. Takakura S., Kohno T., Manda R., et al. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers. Int J Oncol 2001, 18:817-824.
22. Gong C., Mera R., Bravo J.C., et al. KRAS mutations predict progression of preneoplastic gastric lesions. Cancer Epidemiol Biomarkers Prev 1999, 8:167-171.
23. Sugai T., Nakamura S., Uesugi N., et al. Role of DNA aneuploidy, overexpression of p53 gene product, and cellular proliferation in the progression of gastric cancer. Cytometry 1999, 38:111-117.
24. Semba S., Yokozaki H., Yasui W., et al. Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1 (17q21) in young patients with gastric cancer. Int J Oncol 1998, 12:1245-1251.
25. Shiao Y.H., Bovo D., Guido M., et al. Microsatellite instability and/or loss of heterozygosity in young gastric cancer patients in Italy. Int J Cancer 1999, 82:59-62.
26. Mori Y., Sato F., Selaru F.M., et al. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res 2002, 62:3641-3645.
27. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
28. Cummins J.M., Velculescu V.E. Implications of micro-RNA profiling for cancer diagnosis. Oncogene 2006, 25:6220-6227.
29. Croce C.M., Calin G.A. miRNAs, cancer, and stem cell division. Cell 2005, 122:6-7.
30. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
31. Guo H., Ingolia N.T., Weissman J.S., et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
32. Calin G.A., Liu C.G., Sevignani C., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 2004, 101:11755-11760.
33. Iorio M.V., Ferracin M., Liu C.G., et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065-7070.
34. Murakami Y., Yasuda T., Saigo K., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumourous tissues. Oncogene 2006, 25:2537-2545.
35. Takamizawa J., Konishi H., Yanagisawa K., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64:3753-3756.
36. Yanaihara N., Caplen N., Bowman E., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
37. Michael M.Z, O'Conner S.M., van Holst Pellekaan N.G., et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882-891.
38. Calin G.A., Dumitru C.D., Shimizu M., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529.
39. He L., Thomson J.M., Hemann M.T., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
40. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumours defines cancer gene targets. Proc Natl Acad Sci USA 2006, 103:2257-2261.
41. Zhang Z., Li Z., Gao C., et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008, 88:1358-1366.
42. Agarwal R., Mori Y., Cheng Y., et al. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. PLoS One 2009, 4:e8002.
43. Olaru A.V., Selaru F.M., Mori Y., et al. Dynamic changes in the expression of MicroRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis 2011, 17:221-231.
44. Chan S.H., Wu C.W., Li A.F., et al. miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008, 28:907-911.
45. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
46. Shi L., Chen J., Yang J., et al. miR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res 2010, 1352:255-264.
47. Ziyan W., Shuhua Y., Xiufang W., et al. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 2011, 28:1469-1474.
48. Selaru F.M., Olaru A.V., Kan T., et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 2009, 49:1595-1601.
49. Lee T.W., Coates L.C., Birch N.P. Neuroserpin regulates N-cadherin-mediated cell adhesion independently of its activity as an inhibitor of tissue plasminogen activator. J Neurosci Res 2008, 86:1243-1253.
50. Kennedy S.A., van Diepen A.C., van den Hurk C.M., et al. Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage. Thromb Haemost 2007, 97:394-399.